Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 559

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 1C
Chunk 559
---
 Company, including the plans under which Company securities may be acquired by directors, executive officers, employees
and consultants. Further, the compensation committee, to the extent it deems necessary or appropriate, among its several other responsibilities,
will:

    ●
    review
    periodically our Company’s philosophy regarding executive compensation to (i) ensure the attraction and retention of corporate
    officers; (ii) ensure the motivation of corporate officers to achieve the Company’s business objectives; and (iii) align the
    interests of key management with the long-term interests of the Company’s stockholders;

76

    ●
    review
    and approve corporate goals and objectives relating to chief executive officer compensation and other executive officers of Shuttle;

    ●
    make
    recommendations to the board of directors regarding compensation for non-employee directors, and review periodically non- employee
    director compensation in relation to other comparable companies and in light of such factors as the compensation committee may deem
    appropriate; and

    ●
    review
    periodically reports from management regarding funding the Company’s pension, retirement, long-term disability and other management
    welfare and benefit plans.

Nominating
and Corporate Governance Committee

The
nominating and corporate governance committee, which consists of Joshua Schafer (Chair), Steve Richards and Bette Jacobs, recommends
to the board of directors individuals qualified to serve as directors and on committees of the board of directors to advise the board
of directors with respect to the board of directors composition, procedures and committees to develop and recommend to the board of directors
a set of corporate governance principles applicable to the Company, and to oversee the evaluation of the board of directors and the Company’s
management. In addition, the nominating and corporate governance committee will consider diversity of background including diversity
of race, ethnicity, international background, gender and age when evaluating candidates for board of directors membership.

Further,
the nominating and corporate governance committee, to the extent it deems necessary or appropriate, among its several other responsibilities
will:

    ●
    recommend
    to the board of directors and for approval by a majority of independent directors for election by stockholders or appointment by
    the board of directors as the case may be, pursuant to our bylaws and consistent with the board of director’s evidence for
    selecting new directors;

    ●
    review
    the suitability for continued service as a director of each member of the board of directors when his or her term expires or when
    he or she has